BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Prognosis
126 results:

  • 1. Evaluation of Immunohistochemical Expression of alk-1 in Gliomas, WHO Grade 4 and Its Correlation with IDH1-R132H Mutation Status.
    Khairy RA; Momtaz EM; Abd El Aziz AM; Shibel PEE
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):317-323. PubMed ID: 38285799
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells.
    Galiger C; Zohora FT; Dorneburg C; Tews D; Debatin KM; Beltinger C
    BMC Cancer; 2023 Nov; 23(1):1148. PubMed ID: 38007466
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cyanine Dye Conjugation Enhances Crizotinib Localization to Intracranial tumors, Attenuating NF-κB-Inducing Kinase Activity and Glioma Progression.
    Pflug KM; Lee DW; Tripathi A; Bankaitis VA; Burgess K; Sitcheran R
    Mol Pharm; 2023 Dec; 20(12):6140-6150. PubMed ID: 37939020
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature.
    Zhu Z; Liu Y; Xu H; Ning H; Xia Y; Shen L
    J Cardiothorac Surg; 2023 Aug; 18(1):254. PubMed ID: 37653509
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circulating tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative Melanoma.
    Aoude LG; Brosda S; Ng J; Lonie JM; Belle CJ; Patel K; Koufariotis LT; Wood S; Atkinson V; Smithers BM; Pearson JV; Waddell N; Barbour AP; Bonazzi VF
    J Mol Diagn; 2023 Oct; 25(10):771-781. PubMed ID: 37544359
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):539-574. PubMed ID: 37460438
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)].
    ;
    Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(27):2037-2074. PubMed ID: 37455124
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Expression of Anaplastic Lymphoma Kinase (alk) in glioma and possible clinical correlations. A retrospective institutional study.
    Azab MA
    Cancer Treat Res Commun; 2023; 36():100703. PubMed ID: 37271069
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Platelet-Lymphocyte and Neutrophil-Lymphocyte Ratios Are Prognostic Markers for Pheochromocytomas and Paragangliomas.
    Zhong X; Su T; Yang Y; Ye L; Jiang L; Qi Y; Xie J; Jiang Y; Zhou W; Zhang C; Wu L; Zhu H; Ning G; Wang W
    J Clin Endocrinol Metab; 2023 Aug; 108(9):2230-2239. PubMed ID: 36917004
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hit discovery of novel 2-phenyl-substituted 4-amino-6,7-dihydro-5H-cyclopenta[d]pyrimidines as potential anti-glioblastoma therapeutics: Design, synthesis, biological evaluation, and computational screening.
    Khairnar S; Sonawane A; Cheke RS; Kharkar PS; Gaikwad V; Patil S; Aware V
    Drug Dev Res; 2023 May; 84(3):561-578. PubMed ID: 36823756
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. alk Gene Mutation and alk Protein Expression in Advanced Neuroblastoma and the Potential Value in Risk Stratification in Fine-Needle Aspiration Biopsy Samples.
    Bhardwaj N; Rohilla M; Gautam U; Trehan A; Bansal D; Kakkar N; Srinivasan R
    Am J Clin Pathol; 2023 Apr; 159(4):407-415. PubMed ID: 36812383
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Defining the impact of platelet-to-lymphocyte ratio on patient survival with gastric neuroendocrine neoplasm: a retrospective cohort analysis.
    Liang W; Xu X; Liu Y; Cui J; Gao Y; Wang C; Zhuang Z; Zhang K; Xi H; Cai A; Wei B; Chen L
    World J Surg Oncol; 2022 Nov; 20(1):356. PubMed ID: 36348366
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. AIM2 upregulation promotes metastatic progression and PD-L1 expression in lung adenocarcinoma.
    Zheng JQ; Lin CH; Lee HH; Chang WM; Li LJ; Su CY; Lee KY; Chiu HW; Lin YF
    Cancer Sci; 2023 Jan; 114(1):306-320. PubMed ID: 36104978
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants.
    Przybyła W; Gjersvoll Paulsen KM; Mishra CK; Nygård S; Engebretsen S; Ruud E; Trøen G; Beiske K; Baumbusch LO
    PLoS One; 2022; 17(8):e0273280. PubMed ID: 36037157
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma.
    Kuick CH; Tan JY; Jasmine D; Sumanty T; Ng AYJ; Venkatesh B; Chen H; Loh E; Jain S; Seow WY; Ng EHQ; Lian DWQ; Soh SY; Chang KTE; Chen ZX; Loh AHP
    BMC Cancer; 2022 Jun; 22(1):717. PubMed ID: 35768791
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients.
    Shi X; Li H; Xu Y; Nyalali AMK; Li F
    Neurol Sci; 2022 Sep; 43(9):5523-5531. PubMed ID: 35606674
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neuroblastoma: Essential genetic pathways and current therapeutic options.
    Salemi F; Alam W; Hassani MS; Hashemi SZ; Jafari AA; Mirmoeeni SMS; Arbab M; Mortazavizadeh SMR; Khan H
    Eur J Pharmacol; 2022 Jul; 926():175030. PubMed ID: 35605657
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large cell Neuroendocrine Carcinoma.
    Wang Y; Chen Y; Yang Z; Qian F; Hu M; Lu J; Zhang Y; Zhang W; Wang K; Han B
    Ann Surg Oncol; 2022 Sep; 29(9):5666-5678. PubMed ID: 35543906
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diet quality is associated with primary melanoma thickness.
    Hughes MCB; Malt M; Khosrotehrani K; Smithers BM; Green AC
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1745-1750. PubMed ID: 35462440
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Oncogenic Fusions in Gliomas: An Institutional Experience.
    Polivka J; Svajdler M; Priban V; Mracek J; Kasik P; Martinek P; Ptakova N; Sharif Bagheri M; Shetti D; Pesta M; Potuznik P; Topolcan O
    Anticancer Res; 2022 Apr; 42(4):1933-1939. PubMed ID: 35347013
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.